Publications
2 shownAORI-HAP: a multidimensional risk index to predict in-hospital adverse outcomes in asthma exacerbations
Background Despite therapeutic advancements, asthma exacerbations (AEs) remain a major clinical challenge, with immune-inflammatory patterns incompletely characterized. Current ...
Frequent Co-Authors
Researcher Info
- h-index
- 0
- Publications
- 2
- Citations
- 0
- Institution
- Shenyang Pharmaceutical University
External Links
Identifiers
- ORCID
- 0000-0003-0047-3134
Impact Metrics
h-index
0
h-index: Number of publications with at least h citations each.